Cardio Diagnostics Files 2024 10-K
Ticker: CDIOW · Form: 10-K · Filed: Mar 20, 2025 · CIK: 1870144
| Field | Detail |
|---|---|
| Company | Cardio Diagnostics Holdings, Inc. (CDIOW) |
| Form Type | 10-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, diagnostics
Related Tickers: CDIO
TL;DR
CDIO filed its 2024 10-K. Financials are in. Check it out.
AI Summary
Cardio Diagnostics Holdings, Inc. filed its 2024 10-K on March 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Mana Capital Acquisition Corp. until June 29, 2021, is involved in in vitro and in vivo diagnostic substances. Its principal executive offices are located in Chicago, Illinois.
Why It Matters
This filing provides a comprehensive overview of Cardio Diagnostics' financial performance and business operations for the fiscal year 2024, crucial for investors assessing the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a diagnostic company, Cardio Diagnostics operates in a highly regulated and competitive industry, facing risks related to product development, market adoption, and reimbursement.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Previous Fiscal Year (For comparative financial analysis)
Key Players & Entities
- Cardio Diagnostics Holdings, Inc. (company) — Filer of the 10-K
- Mana Capital Acquisition Corp. (company) — Former name of Cardio Diagnostics Holdings, Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-20 (date) — Filing date of the 10-K
- Chicago, Illinois (location) — Location of principal executive offices
FAQ
What is the primary business of Cardio Diagnostics Holdings, Inc.?
Cardio Diagnostics Holdings, Inc. is involved in in vitro & in vivo diagnostic substances, as indicated by its Standard Industrial Classification code.
When was Cardio Diagnostics Holdings, Inc. formerly known as?
The company was formerly known as Mana Capital Acquisition Corp. until June 29, 2021.
Where are Cardio Diagnostics' principal executive offices located?
The company's principal executive offices are located at 311 W. Superior Street, Suite 444, Chicago, IL 60645.
What is the SEC file number for this 10-K filing?
The SEC file number for this 10-K filing is 001-41097.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding Cardio Diagnostics Holdings, Inc. (CDIOW).